Type 1 Diabetes in Adults: Principles and Practice PDF

Type 1 Diabetes in Adults: Principles and Practice PDF

Name:
Type 1 Diabetes in Adults: Principles and Practice PDF

Published Date:
11/16/2007

Status:
[ Active ]

Description:

Publisher:
CRC Press Books

Document status:
Active

Format:
Electronic (PDF)

Delivery time:
10 minutes

Delivery time (for Russian version):
200 business days

SKU:

Choose Document Language:
$79.2
Need Help?
ISBN: 978-0-8493-2622-6

Preface

At a time of dramatic increases in the prevalence of obesity, it is appropriate that type 2 diabetes has received a great deal of attention by the endocrinology community. Clearly, the management of insulin resistance and cardiovascular risk is a critical issue. However, it is equally important to acknowledge and address type 1 diabetes, whose prevalence is also increasing and whose management remains complex. Currently it is estimated that 10-15% of those with diabetes have type 1, and often the diagnosis is challenging since many of those previously thought to have type 2 diabetes actually have late-onset type 1 diabetes (also termed latent autoimmune diabetes in adults, or LADA). Over the last decade the tools for the management of type 1 diabetes have also evolved and so there is an opportunity to more closely replicate normal physiologic insulin secretion with either basal–bolus insulin therapy or continuous subcutaneous insulin infusions. Besides insulin, there are now some added therapies such as pramlintide. While these advancements allow us to better manage our patients with type 1 diabetes, they also add complexity. An updated text to address the concepts behind the care of the person with type 1 diabetes is warranted to review these issues for endocrinologists and primary care providers with an interest in diabetes.

To achieve this goal, we have divided our textbook into four separate sections:

  • In the first section, we review the pathogenesis of type 1 diabetes, including polyglandular autoimmunity, and expand our understanding of LADA.
  • In the second section, we discuss in detail the management of type 1 diabetes, including blood glucose monitoring; diabetes education, nutrition, and special situations; insulin; and pramlintide therapies.
  • In the third section, we review the complications of diabetes: Hyperglycemia and tissue damage, including data from DCCT/EDIC, retinopathy, nephropathy, neuropathy, and hypoglycemia.
  • In the fourth and last section, we discuss special settings and situations such as pregnancy, psychology, including depression and eating disorders, and pancreas and islet transplantation.

We would like to acknowledge the mentoring of our senior editors, Dr. Irl Hirsch, Dr. Satish Garg, Dr. Barry J. Goldstein, and Dr. Matthew Riddle.

We hope you find this text to be informative and practical in your day-to-day management of type 1 diabetes patients and all the complex issues that arise in their care.


Edition : 07
Number of Pages : 282
Published : 11/16/2007
isbn : 978-0-8493-26

History


Related products


Best-Selling Products

EU/EC 1999/103/EC
Published Date: 01/24/2000
DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL amending Council Directive 80/181/EEC on the approximation of the laws of the Member States relating to units of measurement
$8.7
EU/EC 1999/36/EC CORR
Published Date: 06/27/2002
Council Directive on Transportable Pressure Equipment
$8.1
EU/EC 1999/36/EC
Published Date: 04/29/1999
Council Directive on Transportable Pressure Equipment
$21.3
EU/EC 1999/36/EC
Published Date: 04/29/1999
Council Directive on Transportable Pressure Equipment
$13.2
EU/EC 1999/5/EC
Published Date: 03/09/1999
Directive of the European Parliament and of the Council on Radio Equipment and Telecommunications Terminal Equipment and the Mutual Recognition of Their Conformity
$10.8
EU/EC 1999/92/EC
Published Date: 12/16/1999
Minimum Requirements for Improving the Safety and Health Protection of Workers Potentially at Risk from Explosive Atmospheres (15th Individual Directive within the Meaning of Article 16(1) of Directive 89/391/EEC)
$9.6